Limb girdle muscle weakness (LGMW) can result from multiple causes. Early and accurate diagnosis is critical to optimal disease management. The diagnosis can involve clinical, electromyogram, and genetic findings. Patient-specific multidisciplinary management plans, including genetic counseling, should be developed. Currently, there are drugs available for some conditions. Many providers lack the skills to provide optimal care due to the heterogeneous presentation, complex diagnosis, and rarity of LGMW disorders.
After completing this 0.25 contact hour course, learners will be able to:
- Review the recommended algorithm for definitive diagnosis of limb-girdle muscle weakness.
- Discuss available testing options (including genetic and non-genetic components), including optimal use and timing and effective interpretation.
- Describe important facets of a management plan for various types of limb-girdle muscle disorder, including pharmacologic therapies, multiple specialty involvement, and clincial trials consideration.
For more information, including a full outline of this course, please visit http://www.limbgirdlecme.org/education.
The National Society of Genetic Counselors (NSGC) has authorized The France Foundation to offer up to 0.25 Category 1 Contact Hours for the activity: Molecular Diagnosis of Limb-Girdle Muscle Weakness through February 2, 2018. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification. Individuals must be certified at the time of participation in the activity in order to count towards recertification.